Dupilumab and Lichen Planus

Published: 8 May 2025| Version 1 | DOI: 10.17632/kgdr3jhyfx.1
Contributors:
Anagha Srivatsa, Marissa Yaldo, Wasey Rehman, Rafey Rehman, Meena Moossavi, Geoffrey Potts, Darius Mehregan

Description

The purpose of this systematic review was to assess the potential of dupilumab as a treatment for recalcitrant LP and to explore the clinical characteristics of dupilumab-induced LP.

Files

Categories

Dermatology, Immunodermatology, Lichen Planus

Licence